skip to content, health centers and clinics, search, accessibility statement

Viral Hemorrhagic Fevers

Etiologic Agents

Arenaviradae (Lassa, Junin, Machupo, Guanarito, and Sabia), Filoviradae (Marburg and Ebola), Bunyaviradae (Congo-Crimean hemorrhagic fever virus and hantaviruses)and Flaviradae (yellow fever and Dengue) can all cause viral hemorrhagic fever (VHF)


  • Highly infectious after aerosolization
  • Infectious dose can be as low as 1-10 organisms
  • Risk of person-to-person transmission depends on virus


  • Incubation period is 4 - 21 days, depending on virus
  • Clinical presentation would vary by viral agent; however, dominant clinical features of all are a consequence of microvascular damage and changes in vascular permeability. Fever, myalgia, and prostration may evolve to shock, generalized mucous membrane hemmorhage, and neurologic, hematopoietic, or pulmonary involvement.

Laboratory Diagnosis

  • Viral isolation should be handled in a Biosafety Level 3 or 4 facility and may take 3 - 10 days
  • ELISA or reverse transcriptase PCR available for most VHF viruses

Patient Isolation

Isolation room with contact precautions.


Ribavirin (30 mg/kg IV × 1, then 15 mg/kg IV q 6 h × 4 days, 7.5 mg/kg IV q 8 × 6 days) may be helpful for Congo-Crimean hemorrhagic fever or arenaviruses


Licensed vaccine available only for yellow fever

Thanks to Santa Clara County for information provided on this page.

See more information designed specifically for health care providers.